grant
Applying a Targeted Machine Learning and Causal Inference Approach to Analyzing Long-Term Sequelae of COVID-19 Infection Through the National COVID Cohort Collaborative.
Organization UNIVERSITY OF CALIFORNIA BERKELEYLocation BERKELEY, UNITED STATESPosted 4 Sept 2024Deadline 31 Aug 2029
NIHUS FederalResearch GrantFY2025ActemraAcuteAddressAgonistAnti-viral TherapyAreaAtrophic ArthritisB cell differentiation factorB cell stimulating factor 2B-Cell Differentiation FactorB-Cell Differentiation Factor-2B-Cell Stimulatory Factor-2BCDFBSF-2BSF2BerlinBiometricsBiometryBiostatisticsCOVID-19COVID-19 infectionCOVID-19 virus infectionCOVID19 infectionCV-19CaliforniaClinicalCommunicable DiseasesComplexComputer softwareCoronavirus Infectious Disease 2019DataData BasesData ScienceData SetDatabasesDiabetes MellitusDimethylbiguanidineDimethylguanylguanidineDiseaseDisorderDoctor of PhilosophyDrug ModulationDrugsEcologic SystemsEcological SystemsEcosystemElectronic Health RecordEndocrinologyEnvironmentEpidemiologistEpidemiologyFosteringGLP-1 receptorGLP-I receptorGoalsGrantGrippeHPGFHepatocyte-Stimulating FactorHistoryHybridoma Growth FactorIFN-beta 2IFNB2IL-1raIL-6IL1 febrile inhibitorIL1RNIL6 ProteinImmunityImpact evaluationIncidenceInfectionInfectious Disease EpidemiologyInfectious DiseasesInfectious Diseases / LaboratoryInfectious Diseases ResearchInfectious DisorderInfectious EpidemiologyInflammationInfluenzaInformaticsInterleukin-1 Receptor AntagonistInterleukin-6InterventionInvestigatorsLeadershipLearningLongitudinal StudiesLung InflammationMGI-2Machine LearningMediatingMedicationMentorsMentorshipMetabolism and EndocrinologyMetforminMethodsMiceMice MammalsMorbidityMorbidity - disease rateMurineMusMyeloid Differentiation-Inducing ProteinN,N-dimethyl-imidodicarbonimidic diamideNCATSNational Center for Advancing Translational SciencesNational Institutes of HealthNew YorkOutcomePASCPatientsPh.D.PhDPharmaceutical PreparationsPlasmacytoma Growth FactorPlayPneumonitisPost Acute Sequelae of COVID19Post Acute Sequelae of SARS-CoV-2Post Acute Sequelae of SARS-CoV2Post Acute Sequelae of severe acute respiratory syndrome coronavirus 2Post-Acute Sequelae of SARS-CoV-2 InfectionPreparednessPreventative interventionPreventionPublic Health PracticePublic Health SchoolsPulmonary InflammationReadinessReceptor SignalingRecording of previous eventsRecoveryResearchResearch PersonnelResearchersRespiratory syncytial virusRheumatoid ArthritisRoleSARS-CoV-2 infectionSARS-CoV2 infectionSevere acute respiratory syndrome coronavirus 2 infectionSoftwareSourceSterilityTrainingUncertaintyUnited StatesUnited States National Institutes of HealthUniversitiesVaccinationViralViral DiseasesVirusVirus DiseasesWorkWritingacute infectionadverse sequelae of COVIDadverse sequelae of COVID-19adverse sequelae of coronavirus diseaseadverse sequelae of coronavirus disease 2019anakinraassess effectivenesscareerchronic COVID-19 sequelaeco-morbidco-morbiditycohortcommon treatmentcomorbiditycoronavirus disease 2019coronavirus disease 2019 infectioncoronavirus disease-19coronavirus infectious disease-19cytokinedata basedata collected in real worlddetermine effectivenessdiabetesdoubtdrug repositioningdrug repurposingdrug/agenteffectiveness assessmenteffectiveness evaluationelectronic health care recordelectronic health medical recordelectronic health plan recordelectronic health registryelectronic medical health recordepidemiologicepidemiologicalevaluate effectivenessexamine effectivenessexperienceflexibilityflexibleglucagon-like peptide-1 receptorhigh dimensional datahistoriesinfected with COVID-19infected with COVID19infected with SARS-CoV-2infected with SARS-CoV2infected with coronavirus disease 2019infected with severe acute respiratory syndrome coronavirus 2infectious disease treatmentinnovateinnovationinnovativeinsightinterestinterferon beta 2interleukin 1 receptor antagonist proteinintervention for preventionlong haul sequelae of COVID-19long haul sequelae of coronavirus disease 2019long-term sequelaelong-term sequelae of COVID-19long-term sequelae of SARS-CoV-2long-term sequelae of coronavirus disease 2019long-term sequelae of severe acute respiratory syndrome coronavirus 2long-term studylongitudinal outcome studiesmachine based learningmachine learning based methodmachine learning methodmachine learning methodologiesmalemortalitymultidimensional datamultidimensional datasetsnovelpost COVID-19 sequelaepost acute sequelae following COVID-19post-acute sequelae following SARS-CoV-2 infectionpost-acute sequelae of COVID-19post-acute sequelae of acute COVID infectionpost-acute sequelae of coronavirus disease 2019preventpreventingprevention interventionpreventional intervention strategypreventive interventionprospectivereal world datarepurposing agentrepurposing medicationrheumatic arthritissemiparametricskillssocial rolesterilesymptomatologytocilizumabtreatment strategyurine IL-1 inhibitorurine interleukin 1 inhibitorurine-derived IL1 inhibitorvaccination scheduleviral infectionviral infectious disease treatmentvirus infectionvirus-induced disease♂
Description preview
Candidate: I am an epidemiologist in the Division of Biostatistics at the University of California, Berkeley School of Public Health, and I completed my Ph.D. in Epidemiology in August 2022 at UC Berkeley. Since my graduation, I have worked with the Center for Targeted Machine Learning and Causal Inference to apply cutting-edge biostatistical and…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click